TY - JOUR
T1 - Tissue regulatory T cells and neural repair
AU - Ito, Minako
AU - Komai, Kyoko
AU - Nakamura, Toshihiro
AU - Srirat, Tanakorn
AU - Yoshimura, Akihiko
N1 - Funding Information:
This work was supported by JSPS KAKENHI (S) JP17H06175, Challenging Research (P) JP18H05376, and AMED-CREST JP18gm0510019 and JP19gm1110009 and JAPS KAKENHI 17K15667, 19H04817 and 19K16618 for M.I., grants for A.Y., the Takeda Science Foundation, the Uehara Memorial Foundation, the Kanae Foundation and the SENSHIN Medical Research Foundation, Keio Gijuku Academic Developmental Funds.
Publisher Copyright:
© The Japanese Society for Immunology. 2019. All rights reserved.
PY - 2019/2/19
Y1 - 2019/2/19
N2 - Inflammation and immune responses after tissue injury play pivotal roles in the pathology, resolution of inflammation, tissue recovery, fibrosis and remodeling. Regulatory T cells (Tregs) are the cells responsible for suppressing immune responses and can be activated in secondary lymphatic tissues, where they subsequently regulate effector T cell and dendritic cell activation. Recently, Tregs that reside in non-lymphoid tissues, called tissue Tregs, have been shown to exhibit tissue-specific functions that contribute to the maintenance of tissue homeostasis and repair. Unlike other tissue Tregs, the role of Tregs in the brain has not been well elucidated because the number of brain Tregs is very small under normal conditions. However, we found that Tregs accumulate in the brain at the chronic phase of ischemic brain injury and control astrogliosis through secretion of a cytokine, amphiregulin (Areg). Brain Tregs resemble other tissue Tregs in many ways but, unlike the other tissue Tregs, brain Tregs express neural-cell-specific genes such as the serotonin receptor (Htr7) and respond to serotonin. Administering serotonin or selective serotonin reuptake inhibitors (SSRIs) in an experimental mouse model of stroke increases the number of brain Tregs and ameliorates neurological symptoms. Knowledge of brain Tregs will contribute to the understanding of various types of neuroinflammation.
AB - Inflammation and immune responses after tissue injury play pivotal roles in the pathology, resolution of inflammation, tissue recovery, fibrosis and remodeling. Regulatory T cells (Tregs) are the cells responsible for suppressing immune responses and can be activated in secondary lymphatic tissues, where they subsequently regulate effector T cell and dendritic cell activation. Recently, Tregs that reside in non-lymphoid tissues, called tissue Tregs, have been shown to exhibit tissue-specific functions that contribute to the maintenance of tissue homeostasis and repair. Unlike other tissue Tregs, the role of Tregs in the brain has not been well elucidated because the number of brain Tregs is very small under normal conditions. However, we found that Tregs accumulate in the brain at the chronic phase of ischemic brain injury and control astrogliosis through secretion of a cytokine, amphiregulin (Areg). Brain Tregs resemble other tissue Tregs in many ways but, unlike the other tissue Tregs, brain Tregs express neural-cell-specific genes such as the serotonin receptor (Htr7) and respond to serotonin. Administering serotonin or selective serotonin reuptake inhibitors (SSRIs) in an experimental mouse model of stroke increases the number of brain Tregs and ameliorates neurological symptoms. Knowledge of brain Tregs will contribute to the understanding of various types of neuroinflammation.
UR - http://www.scopus.com/inward/record.url?scp=85066456726&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85066456726&partnerID=8YFLogxK
U2 - 10.1093/intimm/dxz031
DO - 10.1093/intimm/dxz031
M3 - Article
C2 - 30893423
AN - SCOPUS:85066456726
SN - 0953-8178
VL - 31
SP - 361
EP - 369
JO - International Immunology
JF - International Immunology
IS - 6
ER -